Emerging applications of liquid biopsy in non-small-cell lung cancer
What are the emerging clinical applications of liquid biopsy in non-small cell lung cancer? Find out the thoughts of expert Dr Petros Christopoulos from Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany, as he reviews key data in the use of liquid biopsy in non-small cell lung cancer as a potential monitoring tool for future clinical applications, and the impact this may have on the treatment landscape
Subscribe to our YouTube channel now: https://www.youtube.com/user/r....oche?sub_confirmatio
Get in touch with us:
https://www.roche.com/
https://twitter.com/roche
https://www.linkedin.com/company/roche
https://www.facebook.com/roche
https://www.instagram.com/roche
Roche has been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the worldโs largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
For more information and insights visit: https://www.roche.com/
-
Category
No comments found